Shareholder Information
Share management and AGM information
Investors
Results, Reports and Presentations
-
Jefferies 2021 London Healthcare Conference
November 16 2021 Download (791KB) -
Indivior Q3 / YTD 2021 Results
October 28 2021 Download (623KB) -
Morgan Stanley 19th Annual Global Healthcare Conference Presentation
September 27 2021 Download (392KB) -
H1 2021 results announcement
July 29 2021 Download (683KB)
Latest News
-
Research Indicates Sustained High Plasma Concentrations of Buprenorphine Reduce Fentanyl-Induced Respiratory Depression in Opioid-Tolerant Participants
January 27 2022 -
Indivior to Present New Data on Buprenorphine Extended-Release at the 2021 Joint International Congress with ALBATROS and the World Association on Dual Disorder (WADD)
December 8 2021 -
Indivior Presents Modelling Data on Interaction Between Buprenorphine and Fentanyl in Opioid-Naïve and Opioid-Tolerant Subjects at the 2021 American Conference of Pharmacometrics
November 8 2021 -
Indivior to Participate in Upcoming November 2021 Healthcare Investor Conferences
November 2 2021 -
Indivior Presents Study at the 2021 National Commission on Correctional Health Care Conference on Factors Impacting Medications for Opioid Use Disorder Treatment Approaches in Criminal Justice-Involved Populations
November 1 2021
